PL371682A1 - Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG) - Google Patents

Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG)

Info

Publication number
PL371682A1
PL371682A1 PL03371682A PL37168203A PL371682A1 PL 371682 A1 PL371682 A1 PL 371682A1 PL 03371682 A PL03371682 A PL 03371682A PL 37168203 A PL37168203 A PL 37168203A PL 371682 A1 PL371682 A1 PL 371682A1
Authority
PL
Poland
Prior art keywords
fdg
fluor
deoxy
glucose
solution
Prior art date
Application number
PL03371682A
Other languages
English (en)
Inventor
Petrus Simon Kruijer
Hector Humberto Knight
Original Assignee
Mallinckrodt Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc. filed Critical Mallinckrodt Inc.
Publication of PL371682A1 publication Critical patent/PL371682A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C07B63/04—Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL03371682A 2002-04-24 2003-04-23 Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG) PL371682A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076638A EP1356827A1 (en) 2002-04-24 2002-04-24 Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution

Publications (1)

Publication Number Publication Date
PL371682A1 true PL371682A1 (pl) 2005-06-27

Family

ID=28685968

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371682A PL371682A1 (pl) 2002-04-24 2003-04-23 Sposób wytwarzania roztworu 2-18F-fluorodeoksy-D-glukozy (18F-FDG)

Country Status (13)

Country Link
US (1) US8182788B2 (pl)
EP (2) EP1356827A1 (pl)
JP (2) JP5132869B2 (pl)
KR (1) KR20050005456A (pl)
CN (1) CN1323724C (pl)
AT (1) ATE422903T1 (pl)
AU (1) AU2003225124B2 (pl)
CA (1) CA2483181C (pl)
DE (1) DE60326220D1 (pl)
IL (2) IL164805A0 (pl)
NO (1) NO329160B1 (pl)
PL (1) PL371682A1 (pl)
WO (1) WO2003090789A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
JP5112062B2 (ja) * 2005-06-14 2013-01-09 日本メジフィジックス株式会社 放射性画像診断剤
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
WO2007148755A1 (ja) * 2006-06-21 2007-12-27 Nihon Medi-Physics Co., Ltd. 新規アミロイド親和性化合物
WO2007148083A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare As Stabilisation of radiopharmaceutical precursors
US20100056826A1 (en) * 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
PT2106808T (pt) * 2006-12-21 2018-03-26 Nihon Mediphysics Co Ltd Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico
JP5258583B2 (ja) * 2007-02-13 2013-08-07 日本メジフィジックス株式会社 放射性画像診断剤の製造方法
KR20100091965A (ko) * 2007-10-24 2010-08-19 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
EP2216052A4 (en) * 2007-10-30 2012-11-21 Nihon Mediphysics Co Ltd USE OF A NEW COMPOUND WITH AFFINITY FOR AMYLOID AND METHOD FOR THE PRODUCTION THEREOF
WO2009057576A1 (ja) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. 新規アミロイド親和性化合物の使用及び製造方法
MX2010005122A (es) * 2007-11-07 2010-08-18 Ge Healthcare Bv Estabilizacion de radiofarmaceuticos.
KR20160030589A (ko) 2009-04-15 2016-03-18 랜티우스 메디컬 이메징, 인크. 아스코르브산을 사용한 방사성 약제 조성물의 안정화
WO2012021882A2 (en) * 2010-08-13 2012-02-16 Siemens Medical Solutions Usa, Inc. Formulation, apparatus and method for stabilizing radiopharmaceuticals
AU2011351550B2 (en) 2010-12-29 2017-02-02 Ge Healthcare Limited Eluent solution
US20130005958A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
US20130004414A1 (en) * 2011-06-30 2013-01-03 General Electric Company Devices and methods for reducing radiolysis of radioisotopes
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
CN109966515A (zh) * 2011-12-21 2019-07-05 通用电气健康护理有限公司 在柠檬酸盐缓冲液中的18F-Fluciclovine组合物
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
FR3054445B1 (fr) * 2016-07-26 2019-07-05 Laboratoires Cyclopharma Synthese d'une composition d'agent radioactif
GB202005282D0 (en) 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
SE9002117L (sv) * 1990-06-14 1991-08-26 Nils Elander Mikrovaagsanordning foer behandling av precessvaetskor
EP0538402B1 (en) 1990-07-06 2006-03-08 Mallinckrodt Inc. Method of preparing a radioactive rhenium complex solution
JPH0797340A (ja) * 1993-06-03 1995-04-11 Terumo Corp Ｍｒｉ造影剤組成物
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
BR9712281A (pt) * 1996-10-07 1999-08-31 Du Pont Pharm Co Reagentes, kit, agente de ligação de ltb4 radiorotulado, método para detectar locais de infecção e inflamação em um mamífero, método para a formação da imagem de locais de infecção e inflamação em um mamífero, método para diagnosticar doença em um mamífero associado com minfecção e inflamação, compostos e método de tratamento de doença em um mamífero associado com infecção e inflamação

Also Published As

Publication number Publication date
NO20045070L (no) 2004-11-22
CA2483181A1 (en) 2003-11-06
EP1356827A1 (en) 2003-10-29
JP2010248244A (ja) 2010-11-04
IL164805A (en) 2009-06-15
IL164805A0 (en) 2005-12-18
CN1323724C (zh) 2007-07-04
WO2003090789A1 (en) 2003-11-06
EP1496946B1 (en) 2009-02-18
ATE422903T1 (de) 2009-03-15
KR20050005456A (ko) 2005-01-13
CA2483181C (en) 2011-06-28
US8182788B2 (en) 2012-05-22
DE60326220D1 (de) 2009-04-02
EP1496946A1 (en) 2005-01-19
CN1646175A (zh) 2005-07-27
US20050175536A1 (en) 2005-08-11
JP5132869B2 (ja) 2013-01-30
JP2006500319A (ja) 2006-01-05
NO329160B1 (no) 2010-08-30
AU2003225124A1 (en) 2003-11-10
AU2003225124B2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
IL164805A0 (en) Method for obtaining a2-18f-fluor-2-deoxy-d-glucose(18f-fdg)-solution
WO2007014110A3 (en) Method and system for evaluating delivered dose
DE60233234D1 (en) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
GB2411990B (en) Improved architecture for generating intermediate representations for program code conversion
NO20033481D0 (no) Integrerte reaktorer, samt fremgangsmåte for fremstilling og bruk av samme
WO2006092800A3 (en) System and method for scanning an intraoral cavity
WO2007067297A3 (en) External fixation system
WO2007070551A3 (en) Providing authentication of remotely collected external sensor measures
ATE539698T1 (de) Zahnärztliches implantatsystem
WO2008133108A1 (ja) エポキシシリコーン及びその製造方法、並びに、それを用いた硬化性樹脂組成物とその用途
WO2007010534A3 (en) Imaging protocols
GB2401351B (en) Frame assembly for pushchair,stroller or the like
AU2003294361A8 (en) Selectively locking device
EP1829936A4 (en) ACTIALLY HARDENABLE COMPOSITION, ACTIALLY HARDENABLE INK AND IMAGING METHOD
WO2002019108A8 (en) Method for providing bitwise constraints for test generation
NO20091735L (no) Radiofluorering
NL1025709A1 (nl) 3-(1-[3-(1,3-Benzothiazol-6-yI)propylcarbamoyl]cycloalkyI)propaanzuurderivaten Derivatives als NEP-remmers.
DE502006000814D1 (de) Medizinisches, insbesondere dentalmedizinisches Handstück
DE50306947D1 (de) Sequenzgestell
CA2585802A1 (en) Industrial process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-3-oxo-17.alpha.pregn-4-ene-21-carboxylic acid.gamma.-lactone and key-intermediates for this process
WO2007017794A3 (en) Skin-treatment device
EP1491951A3 (en) Positive-working resist composition
GB2382393B (en) Fastening element
WO2009056837A3 (en) Materials and methods for medical imaging
나의 et al. Copyright (C) 2003 NuriMedia Co., Ltd.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed